NorthCrest Asset Manangement LLC Purchases New Holdings in Astrana Health, Inc. (NASDAQ:ASTH)

NorthCrest Asset Manangement LLC bought a new position in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 460,895 shares of the company's stock, valued at approximately $26,704,000. Astrana Health comprises about 0.8% of NorthCrest Asset Manangement LLC's portfolio, making the stock its 28th biggest holding. NorthCrest Asset Manangement LLC owned about 0.82% of Astrana Health at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Louisiana State Employees Retirement System acquired a new stake in Astrana Health during the third quarter worth $1,165,000. Guidance Capital Inc. acquired a new stake in shares of Astrana Health in the third quarter valued at $724,000. SG Americas Securities LLC acquired a new stake in shares of Astrana Health in the third quarter valued at $680,000. Handelsbanken Fonder AB acquired a new stake in shares of Astrana Health in the third quarter valued at $492,000. Finally, Granite Bay Wealth Management LLC acquired a new stake in shares of Astrana Health in the third quarter valued at $290,000. Institutional investors and hedge funds own 52.77% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on ASTH shares. Stifel Nicolaus lifted their price objective on Astrana Health from $48.00 to $60.00 and gave the company a "buy" rating in a research note on Thursday, August 1st. Truist Financial lifted their price objective on Astrana Health from $50.00 to $59.00 and gave the company a "buy" rating in a research note on Friday, August 9th. Robert W. Baird lifted their price objective on Astrana Health from $54.00 to $67.00 and gave the company an "outperform" rating in a research note on Thursday, August 15th. KeyCorp started coverage on Astrana Health in a research note on Friday, October 11th. They issued a "sector weight" rating for the company. Finally, TD Cowen started coverage on Astrana Health in a research note on Monday, October 14th. They issued a "buy" rating and a $66.00 price objective for the company. One research analyst has rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Astrana Health has an average rating of "Buy" and a consensus price target of $62.00.

Astrana Health Stock Up 0.1 %

NASDAQ:ASTH traded up $0.04 during midday trading on Friday, reaching $55.68. The company had a trading volume of 117,361 shares, compared to its average volume of 197,634. The firm has a market capitalization of $3.12 billion, a price-to-earnings ratio of 42.18, a PEG ratio of 2.20 and a beta of 1.21. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.62. The stock's fifty day simple moving average is $54.09 and its 200-day simple moving average is $46.38. Astrana Health, Inc. has a 12-month low of $28.86 and a 12-month high of $63.20.

Astrana Health (NASDAQ:ASTH - Get Free Report) last posted its earnings results on Wednesday, August 7th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.01. Astrana Health had a return on equity of 10.71% and a net margin of 4.30%. The business had revenue of $486.30 million during the quarter, compared to the consensus estimate of $440.68 million. During the same period in the previous year, the business earned $0.28 EPS. The business's quarterly revenue was up 39.7% on a year-over-year basis. On average, sell-side analysts anticipate that Astrana Health, Inc. will post 1.33 earnings per share for the current fiscal year.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.